Skip to main content
NCBI home page
Gut logoLink to Gut
. 1991 Mar;32(3):321–324. doi: 10.1136/gut.32.3.321

Limitations of faecal chymotrypsin as a screening test for chronic pancreatitis.

L Riedel 1, A R Walker 1, I Segal 1, A E Mohamed 1, A E Smyth 1, B Daya 1, I Naik 1
PMCID: PMC1378844  PMID: 2013430

Abstract

Faecal chymotrypsin was measured in patients with chronic pancreatitis and in healthy black urban and rural control subjects. In the patients, significantly lower values of faecal chymotrypsin were obtained (mean (SD) 2.4 1.79 U/g stool) whereas in urban control subjects, values were within the normal range (mean (SD) 13.2 (11.9)). In rural black control subjects, however, the faecal chymotrypsin value was significantly lower (mean (SD) 7.1 (5.1)) than in urban black control subjects. It is suggested that faecal pH may influence faecal chymotrypsin values. The mean faecal pH in rural black subjects (pH 6.14) was significantly lower than that in urban control subjects (pH 6.77) and in patients with chronic pancreatitis (pH 6.61). Moreover, mean faecal chymotrypsin is high (20.0 U/g stool) at a pH greater than 7. Between pH 6 and 7 the mean value drops to 8.6 U/g stool and below pH 6 mean faecal chymotrypsin is in the abnormal range (4.4 U/g stool). Hence, low values for faecal chymotrypsin may be due to lower faecal pH (less than 6) in healthy control subjects. For diagnostic purposes, the faecal pH value should be determined if a low faecal chymotrypsin value is obtained.

Full text

PDF
321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammann R. W., Akovbiantz A., Häcki W., Largiadèr F., Schmid M. Diagnostic value of the fecal chymotrypsin test in pancreatic insufficiency, particularly chronic pancreatitis: correlation with the pancreozymin-secretin test, fecal fat excretion and final clinical diagnosis. Digestion. 1981;21(6):281–289. doi: 10.1159/000198578. [DOI] [PubMed] [Google Scholar]
  2. BANWELL J. G., LEONARD P. J., LOBO R. M. MEASUREMENT OF TRYPSIN AND CHYMOTRYPSIN ACTIVITY IN STOOLS TO DETECT CHRONIC PANCREATIC DISEASE. Gut. 1965 Apr;6:143–145. doi: 10.1136/gut.6.2.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bode C., Bode J. C. Usefulness of a simple photometric determination of chymotrypsin activity in stools--results of a multicentre study. Clin Biochem. 1986 Dec;19(6):333–337. doi: 10.1016/s0009-9120(86)80005-4. [DOI] [PubMed] [Google Scholar]
  4. Bode J. C., Dürr H. K. Bestimmung von Chymotrypsin im Stuhl als Suchtest für eine exokrine Pankreasinsuffizienz. Dtsch Med Wochenschr. 1977 Feb 4;102(5):165–166. doi: 10.1055/s-0028-1104860. [DOI] [PubMed] [Google Scholar]
  5. Burkitt D. P., Walker A. R., Painter N. S. Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease. Lancet. 1972 Dec 30;2(7792):1408–1412. doi: 10.1016/s0140-6736(72)92974-1. [DOI] [PubMed] [Google Scholar]
  6. DelMar E. G., Largman C., Brodrick J. W., Geokas M. C. A sensitive new substrate for chymotrypsin. Anal Biochem. 1979 Nov 1;99(2):316–320. doi: 10.1016/s0003-2697(79)80013-5. [DOI] [PubMed] [Google Scholar]
  7. Dürr H. K., Otte M., Forell M. M., Bode J. C. Fecal chymotroypsin: a study on its diagnostic value by comparison with the secretin-cholecystokinin test. Digestion. 1978;17(5):404–409. doi: 10.1159/000198143. [DOI] [PubMed] [Google Scholar]
  8. Dürr H. K., Schneider R., Bode C., Bode J. C. Fecal chymotrypsin: study on some characteristics of the enzyme. Digestion. 1978;17(5):396–403. doi: 10.1159/000198142. [DOI] [PubMed] [Google Scholar]
  9. Gilat T., Gelman-Malachi E., Ronen O. Chymotrypsin output in the stools in pancreatic and other diseases. Am J Gastroenterol. 1976 Aug;66(2):140–145. [PubMed] [Google Scholar]
  10. Goldberg D. M., Campbell R., Roy A. D. Fate of trypsin and chymotrypsin in the human small intestine. Gut. 1969 Jun;10(6):477–483. doi: 10.1136/gut.10.6.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lami F., Callegari C., Miglioli M., Barbara L. A single-specimen fecal chymotrypsin test in the diagnosis of pancreatic insufficiency: correlation with secretin-cholecystokinin and NBT-PABA tests. Am J Gastroenterol. 1984 Sep;79(9):697–700. [PubMed] [Google Scholar]
  12. Oettlé G. J., Segal I. Bowel function in an urban black African population. Dis Colon Rectum. 1985 Oct;28(10):717–720. doi: 10.1007/BF02560281. [DOI] [PubMed] [Google Scholar]
  13. PELOT D., GROSSMAN M. I. Distribution and fate of pancreatic enzymes in small intestine of the rat. Am J Physiol. 1962 Feb;202:285–288. doi: 10.1152/ajplegacy.1962.202.2.285. [DOI] [PubMed] [Google Scholar]
  14. Sale J. K., Goldberg D. M., Thjodleifsson B., Wormsley K. G. Trypsin and chymotrypsin in duodenal aspirate and faeces in response to secretin and cholecystokinin-pancreozymin. Gut. 1974 Feb;15(2):132–138. doi: 10.1136/gut.15.2.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Samelson S. L., Nelson R. L., Nyhus L. M. Protective role of faecal pH in experimental colon carcinogenesis. J R Soc Med. 1985 Mar;78(3):230–233. doi: 10.1177/014107688507800311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Walker A. R., Walker B. F., Richardson B. D. Bowel transit times in Bantu populations. Br Med J. 1970 Jul 4;3(5713):48–49. doi: 10.1136/bmj.3.5713.48-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Walker A. R., Walker B. F., Walker A. J. Faecal pH, dietary fibre intake, and proneness to colon cancer in four South African populations. Br J Cancer. 1986 Apr;53(4):489–495. doi: 10.1038/bjc.1986.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wormsley K. G., Goldberg D. M. The interrelationships of the pancreatic enzymes. Gut. 1972 May;13(5):398–412. doi: 10.1136/gut.13.5.398. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES